Novo Holdings



Novo Holdings A/S is the holding company of the Novo Group, wholly-owned by the Novo Nordisk Foundation.

Peter Hahr
Thomas Dyrberg
Managing Partner, Novo Ventures
Christoffer Søderberg
Managing Partner, Principal Investments
Petrina Knowles
Senior Vice President, People & Organization
Søren Møller
Managing Partner, Novo Seed
Morten Beck Jørgensen
Managing Partner, Financial Investments
Steffen P. Lüders
Senior Vice President, Communication
Amit Kakar
Senior Partner, Head of Novo Holdings Asia
André Leue
Senior Partner, Principal Investments
Charles Patten

No teams yet!

No jobs yet!

Team announcement

Abhijeet Lele and Jon Levy named Senior Partners at Principal Investments

Abhijeet Lele and Jon Levy named Senior Partners at Principal Investments

Life science investment company Novo Holdings A/S has appointed Abhijeet Lele and Jon Levy Senior Partners at Principal Investments, a subsidiary focused on large investments. The pair will both be based in Boston, focusing on screening new business opportunities and driving growth in current portfolios. Mr. Lele has also been named Head of Principal Investments in the United States. "With Abhijeet and Jon, we are welcoming two seasoned life science investors who complement each other well to lead our team in the US,” said Novo Holdings Head of Principal Investments Christoffer Søderberg. “With this on the ground presence in the US, we will be better plugged into the ecosystem to manage existing investments and execute new investment opportunities. Novo Holdings has a clear ambition of building on its position as the world's leading life science investor and establishing a direct presence for the Principal Investments team in the US is a significant step in consolidating that position." Mr. Lele comes to Novo Holdings from Temasek, where he served as US Head of Healthcare. He has more than 20 years of experience in life sciences investment, both in the U.S. and Europe. Mr. Levy is a trained investment banker, with more than a decade of experience working in life science buyouts and private equity transactions. He most recently served as Managing Director of the Healthcare department at private equity firm CVC Capital Partners.

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.